- Home
- RVMD
RVMD
Revolution Medicines Inc.
as 05-09-2025 4:00pm EST
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $68.75 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $29.17 - $62.40 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 153.62% |
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
2 days ago
Q1 2025 Revolution Medicines Inc Earnings Call
GuruFocus.com
2 days ago
Revolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
MT Newswires
2 days ago
Revolution Medicines Q1 Net Loss Widens
GlobeNewswire
2 days ago
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
GlobeNewswire
9 days ago
Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025
MT Newswires
11 days ago
Sector Update: Health Care Stocks Swing Between Small Gains, Losses
MT Newswires
11 days ago
Revolution Medicines Shares Rise on 'Encouraging' Phase 1 Lung Cancer Trial Data
Benzinga
12 days ago
Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?
Compare RVMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.